Navigation Links
Lexicon Pharmaceuticals Provides Clinical Pipeline Update and Reports 2013 First Quarter Financial Results
Date:5/10/2013

.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor StatementThis press release contains "forward-looking statements", including statements relating to Lexicon's clinical development of LX4211, telotristat etiprate (LX1032) and LX1033, including characterizations of the results of and projected timing of clinical trials of such compounds, and the potential therapeutic and commercial potential of LX4211, telotristat etiprate (LX1032) and LX1033.  In addition, this press release also contains forward-looking statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances and intellectual property, as well as other matters that are not historical facts or information.  All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX4211, telotristat etiprate (LX1032) and LX1033 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements.  Information identifying such important fa
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
2. Lexicon to Report First Quarter Financial Results on May 10, 2013
3. Lexicon To Present At The Needham Healthcare Conference
4. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
5. Lexicon To Present At The BIO CEO & Investor Conference
6. Lexicon Pharmaceuticals To Present At The Piper Jaffray Annual Healthcare Conference
7. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
8. Lexicon to Provide Third Quarter 2012 Financial Results
9. Lexicon Pharmaceuticals To Present At The Stifel Nicolaus 2012 Healthcare Conference
10. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
11. Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... YORK, Pa. , Aug. 29, 2014  Unilife ...  ASX: UNS) announced today that it intends to release ... and year ended June 30, 2014 after market trading ... Management has scheduled a conference call for 4:30 p.m. ... 10, 2014 at 6:30 a.m. AEST), to review the Company,s ...
(Date:8/29/2014)... 2014  Abaxis, Inc. (NasdaqGS: ABAX ), ... consumables to the medical, research and veterinary markets, announced ... Executive Officer, will present at the CL King 12 ... September 9, 2014 at 12:30 p.m. ET. The conference ... in New York City . ...
(Date:8/29/2014)... 2014 Research and Markets  has announced ... Repair Devices Market 2014-2018" report to their offering. ... of cells that connect, support, or surround bones. There ... tendons, ligaments, cartilage, fascia, and other fibrous tissues. Repetitive ... with age result in wear and tear in these ...
Breaking Medicine Technology:Unilife Corporation to Announce Financial Results for Fiscal Year 2014 Fourth Quarter and Year End on Tuesday, September 9, 2014 2Abaxis, Inc. to Present at CL King's 12th Annual Best Ideas Conference 2014 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3
... Oct. 7 Marine biotechnology specialist Azantis, Inc ... to its clients, in an effort to provide continued ... an agreement with SafetyCall International , Azantis has ... and Post-Market Surveillance services. SafetyCall medical ...
... Oct. 7 Spherix Incorporated (Nasdaq: ... in diabetes, metabolic syndrome and atherosclerosis; and providers of ... and pharmaceutical companies, today announced that it has entered ... its Series B Convertible Preferred Stock and warrants to ...
Cached Medicine Technology:Azantis Announces New Consumer Safety Program 2Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants 2Spherix Announces Institutional Investors Purchase $5.25 Million of Convertible Preferred Stock and Warrants 3
(Date:9/2/2014)... 02, 2014 NOVAtime Technology, Inc. ... development company, announced today that Avon Health Center, ... upgraded to NOVAtime 4000 Time and Attendance ... NOVAtime’s latest smart clock, the NT7000 . ... of Connecticut is an award-winning nursing facility that ...
(Date:9/2/2014)... VA (PRWEB) September 02, 2014 During ... important to prepare for the winter months to prevent ... Northern Virginia real estate company, suggests these fall ... Clean gutters and downspouts frequently throughout fall to prevent ... can lead to wood rot problems, pest infestations, wet ...
(Date:9/1/2014)... September 02, 2014 Citrus Park ... root canal therapy based in Tampa, Florida, announced the ... features helpful information aimed at making the patient experience ... eye-catching design featuring updated images that truly make the ... our website experience just as pleasant as our office ...
(Date:9/1/2014)... September 02, 2014 PAINWeek, the National ... the American Pain Society (APS) will return to the ... expertise in pain management to the agenda. This activity ... no fee to attend this program. , On Thursday, ... activity that complies with the FDA’s Risk Evaluation and ...
(Date:9/1/2014)... September 02, 2014 UWDress.com, a well-known ... of 2014 lime green bridesmaid dresses for ... been added to the company’s online category. What’s more, ... 67% off. The special offer is specially launched to ... UWDress.com’s fashionable bridesmaid gowns have won great appreciation from ...
Breaking Medicine News(10 mins):Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 3Health News:Northern Virginia Real Estate Company Pasquali Realty Group Suggests These Maintenance Tips for Homeowners This Fall 2Health News:Citrus Park Endodontics Launches New Website to Better Serve Patients 2Health News:American Pain Society Returns with REMS Training at PAINWeek 2014 in Las Vegas 2Health News:2014 Lime Green Bridesmaid Dresses Offered At UWDress.com 2
... their families living with ... all types of epilepsy, ... series "Heroes" and father of an 11-year-old son with,epilepsy - joined ... community awareness activities that will empower other,people living with the condition. ...
... WASHINGTON, March 27 SEIU Spokesperson,Andrew ... members, resources, UHW-W leaders should focus ... contracts this year. UHW-W members,deserve better ... at risk by a distracted,UHW-W leadership.", ...
... DENVER, March 27 On March 25, 2008, ... the Gadolinium-Based Contrast,Agents Product Liability Multi-District Litigation in ... serve on the Plaintiffs, Steering,Committee. One of these ... PSC,reports directly to Judge Polster, and is responsible ...
... preferred it to product requiring three injections a day ... that a once-daily shot of insulin appears to control ... just as well as injecting insulin three times a ... (Lantus), is already on the market, as is insulin ...
... Ill., March 27 Lifeway Foods,Inc. (Nasdaq: LWAY ... of other natural and organic dairy products, is opening ... Starfruit in Chicago. The,shop will offer several flavors of ... kefir parfaits, and smoothie-style kefir drinks., The new ...
... you know that teledentistry can help provide orthodontic treatment ... provide diagnostic clues to your systemic health? Have you ... growth with other metabolic processes?, These are but a ... will be presented when the American Association for Dental ...
Cached Medicine News:Health News:Once-Daily Insulin Shot Proves Effective in Study 2Health News:Once-Daily Insulin Shot Proves Effective in Study 3Health News:Lifeway Foods Launches Starfruit, New 'Kefir Boutique' Cafe Selling Frozen Kefir & Kefir Smoothies 2Health News:Dental scientists convene in Dallas 2Health News:Dental scientists convene in Dallas 3Health News:Dental scientists convene in Dallas 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: